Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesThe use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
Respiratory Medicine, 06/30/09
Holgate S et al. - Based on clinical trial data analysis, it is recommended that treatment response is evaluated by the physician after 16 weeks of therapy. Treatment should only be continued in responders, i.e. those judged by the physician to have achieved a marked improvement or complete asthma control. Omalizumab is generally well tolerated. Anaphylactic-like reactions are rare and less common than encountered with other biologics.
Today in Cardiovascular/Pulm...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09
Pediatric Asthma: An Integrative Approach to Care
Nutrition in Clinical Practice, 10/22/09
From asthma severity to control: a shift in clinical practice
Primary Care Respiratory Journal, 10/19/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Zinc: role in immunity, oxidative stress and chronic inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09
Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets, 10/09/09
Sponsor
Article Search
Sponsor